HLS Therapeutics Stock Forecast, Price & News

HLS Therapeutics (TSE:HLS) Frequently Asked Questions

Is HLS Therapeutics a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for HLS Therapeutics in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HLS Therapeutics stock.
View analyst ratings for HLS Therapeutics or view top-rated stocks.

How has HLS Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

HLS Therapeutics' stock was trading at C$18.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HLS shares have decreased by 20.0% and is now trading at C$15.00.
View which stocks have been most impacted by COVID-19.

When is HLS Therapeutics' next earnings date?

HLS Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, March 17th 2022.
View our earnings forecast for HLS Therapeutics.

How were HLS Therapeutics' earnings last quarter?

HLS Therapeutics Inc. (TSE:HLS) announced its earnings results on Thursday, November, 4th. The company reported ($0.08) EPS for the quarter, beating the Zacks' consensus estimate of ($0.15) by $0.07. The firm had revenue of $18.96 million for the quarter, compared to analysts' expectations of $19.56 million.
View HLS Therapeutics' earnings history.

How often does HLS Therapeutics pay dividends? What is the dividend yield for HLS Therapeutics?

HLS Therapeutics declared a quarterly dividend on Wednesday, November 3rd. Shareholders of record on Friday, January 28th will be given a dividend of 0.05 per share on Tuesday, March 15th. This represents a $0.20 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Thursday, January 27th.
View HLS Therapeutics' dividend history.

Is HLS Therapeutics a good dividend stock?

HLS Therapeutics pays an annual dividend of C$0.16 per share and currently has a dividend yield of 1.32%.
View HLS Therapeutics' dividend history.

What price target have analysts set for HLS?

4 brokerages have issued twelve-month target prices for HLS Therapeutics' shares. Their forecasts range from C$26.00 to C$36.00. On average, they expect HLS Therapeutics' share price to reach C$31.33 in the next year. This suggests a possible upside of 108.9% from the stock's current price.
View analysts' price targets for HLS Therapeutics or view top-rated stocks among Wall Street analysts.

Who are HLS Therapeutics' key executives?

HLS Therapeutics' management team includes the following people:

• Mr. William M. Wells M.B.A., B.A., MBA, Co-Founder & Exec. Chairman (Age 60, Pay $587.15k)
• Mr. Gilbert Godin, Co-Founder, Pres, CEO & Director (Age 62, Pay $800.32k)
• Mr. Gregory David Gubitz L.L.B., B.A., LL.B, Co-Founder & Director (Age 64, Pay $1.93M)
• Mr. Tim Hendrickson M.B.A., Chief Financial Officer (Age 49, Pay $356.14k)
• Mr. Sanjiv Sharma, Chief Commercial Officer (Age 65, Pay $460.14k)
• Dr. Hemanth Jacob Varghese, Sr. VP of Strategy & Operations (Age 45, Pay $382.25k)
• Mr. Ryan C. Lennox B.A., J.D., Sr. Vice-Pres of Legal, HR & Compliance and Corp. Sec. (Age 40)
• Ms. Patricia Perry, Vice-Pres Human Resource
• David Spence, Corp. Controller (Age 53)

Who are some of HLS Therapeutics' key competitors?

Some companies that are related to HLS Therapeutics include Aurora Cannabis (ACB), Hydropothecary (THCX), Knight Therapeutics (GUD), OrganiGram (OGI), Amryt Pharma (AMYT), Benchmark (BMK), Supreme Cannabis (FIRE), HEXO (HEXO), ESSA Pharma (EPI), ICC Labs (ICC), Leaf Mobile (LEAF), Medexus Pharmaceuticals (MDP), Diurnal Group (DNL), BioSyent (RX) and Science in Sport (SIS).
View all of HLS's competitors.

What other stocks do shareholders of HLS Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HLS Therapeutics investors own include Cargojet (CJT), Fairfax Financial (FFH), Fortis (FTS), Aurora Cannabis (ACB), Aphria (APHA), Alimentation Couche-Tard (ATD.B), BlackBerry (BB), BCE (BCE), Bank of Montreal (BMO) and Bank of Nova Scotia (BNS).

What is HLS Therapeutics' stock symbol?

HLS Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HLS."

How do I buy shares of HLS Therapeutics?

Shares of HLS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is HLS Therapeutics' stock price today?

One share of HLS stock can currently be purchased for approximately C$15.00.

How much money does HLS Therapeutics make?

HLS Therapeutics has a market capitalization of C$486.77 million and generates C$60.80 million in revenue each year.

How many employees does HLS Therapeutics have?

HLS Therapeutics employs 88 workers across the globe.

What is HLS Therapeutics' official website?

The official website for HLS Therapeutics is www.hlstherapeutics.com.

How can I contact HLS Therapeutics?

The company can be reached via phone at 647-495-9000.